Patents for C12R 1 - Micro-organisms (92,025)
05/1992
05/05/1992US5110906 Derivatives of soluble T-4
05/05/1992US5110905 Activated Bacillus thuringienses delta-endotoxin produced by an engineered hybrid gene
05/05/1992US5110811 Antibody inhibitors
05/05/1992US5110739 Process for selective fermentation with mutants of Pediococcus halophilus
05/05/1992US5110738 Genetic engineering; hybridomas of melanoma and spleen cells
05/05/1992US5110736 Tissue plasminogen activator
05/05/1992US5110735 Thermostable purified endoglucanase from thermophilic bacterium acidothermus cellulolyticus
05/05/1992US5110729 Method of producing peptides using baculovirus vectors in cultured cells
05/05/1992CA1300060C Method of producing hyaluronic acid
05/05/1992CA1300059C Antibiotic vermisporin, process for the production thereof and pharmaceutical composition comprising it as an active antibacterial agent
05/05/1992CA1300058C Process for preparing activated killer cells
05/05/1992CA1300055C Biocontrol of grey-mold in pome fruits using acremonium breve
05/05/1992CA1300052C Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof
05/05/1992CA1300023C Lactobacillus bifidus proliferation promoting composition
05/05/1992CA1300008C Acid lyophilised pharmaceutical formulation of tissue plasminogen activator
04/1992
04/30/1992WO1992007085A1 HUMAN CELL LINE STABLY EXPRESSING 5cDNAs ENCODING PROCARCINOGEN-ACTIVATING ENZYMES
04/30/1992WO1992007084A1 Purified cdw52-specific antibodies
04/30/1992WO1992007083A1 Antibodies against the urokinase receptor and their use
04/30/1992WO1992007082A1 Process for producing optically active 1,3-butanediol
04/30/1992WO1992007079A1 Transformation selection marker system adapted for penicillium
04/30/1992WO1992007078A1 Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making same
04/30/1992WO1992007075A1 Preparation of chimaeric antibodies using the recombinant pcr strategy
04/30/1992WO1992007073A1 Osteogenic peptides
04/30/1992WO1992007067A1 Novel proteases
04/30/1992WO1992007066A1 A 170kD MEMBRANE-BOUND PROTEASE USEFUL IN DIAGNOSIS OF MALIGNANT CELLULAR TRANSFORMATION
04/30/1992WO1992007064A1 Processing of yeast refuse and resulting product
04/30/1992WO1992007002A1 A collagen binding protein as well as its preparation
04/30/1992WO1992007001A1 Hepatitis c virus antibody
04/30/1992WO1992006989A1 Varicella-zoster virus antigen
04/30/1992WO1992006988A1 Method for the production of catalytic rna in bacteria
04/30/1992WO1992006711A1 Blood coagulation protein antagonists and uses therefor
04/30/1992WO1992004448A3 Human mitochondrial nad(p)+-dependent malate enzyme
04/30/1992WO1992003559A3 Test system for checking the activity of viral proteinases
04/30/1992CA2111123A1 A 170kd membrane-bound protease useful in diagnosis of malignant cellular transformation
04/30/1992CA2094372A1 Blood coagulation protein antagonists and uses therefor
04/30/1992CA2093919A1 Hepatitis c virus antibody
04/30/1992CA2071854A1 Method for the production of catalytic rna in bacteria
04/30/1992CA2054302A1 Monoclonal antibody-containing agent
04/30/1992CA2054128A1 Process for the production of analogues of immunomycin
04/29/1992EP0483115A2 Regulatory region for heterologous gene expression in yeast
04/29/1992EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD
04/29/1992EP0482909A2 Process for producing antibiotics
04/29/1992EP0482908A2 Process for producing streptovaricin
04/29/1992EP0482879A2 Protease from Bacillus licheniformis
04/29/1992EP0482844A2 GL-7ACA acylase
04/29/1992EP0482795A1 Preparation of novel invermectin compounds
04/29/1992EP0482714A1 Increased production of thermus aquaticus DNA polymerase in E. coli
04/29/1992EP0482671A1 Vaccine against varicella-zoster virus
04/29/1992EP0482544A2 Spheroplast fusions of phaffia rhodozyma cells
04/29/1992EP0482543A1 Oasomycine, method of its preparation and its use
04/29/1992EP0482176A1 Monoclonal antibodies specific for toxin b of clostridium difficile
04/29/1992EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides
04/29/1992EP0482124A1 Somatotropin analogs.
04/29/1992EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus
04/29/1992EP0482077A1 Method for producing novel polyester biopolymers
04/29/1992EP0482018A1 Toxin uses
04/29/1992EP0482017A1 Acaricidal compositions and process for preparing same
04/29/1992EP0092574B1 Oligonucleotide therapeutic agent and methods of making same
04/29/1992CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus
04/28/1992US5109120 Extended blood circulation life
04/28/1992US5109119 Concentrated and equilibrated in polyoxyethylene glycol solution
04/28/1992US5109113 Membrane anchor fusion polypeptides
04/28/1992US5108992 Macrolide compounds
04/28/1992US5108921 Method for enhanced transmembrane transport of exogenous molecules
04/28/1992US5108919 Dna sequences encoding yeast ubiquitin hydrolase
04/28/1992US5108917 Process for the preparation of ibuprofen
04/28/1992US5108916 Process for stereoselectively hydrolyzing, transesterifying or esterifying with immobilized isozyme of lipase from candida rugosa
04/28/1992US5108914 Process for the synthesis of l-alpha-amino acids
04/28/1992US5108900 For use in immunoassay to detect pesticides in foods and the environment
04/28/1992US5108894 Recombinant dna having a nucleotide sequence coding for protein G or fragment thereof which is capable of specific bidning with immunoglobulins
04/28/1992US5108760 Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
04/28/1992US5108457 Enzymatic peracid bleaching system with modified enzyme
04/28/1992CA2054239A1 Process for the preparation of carebastine
04/28/1992CA1299752C Optical decoding technique for speech recognition
04/28/1992CA1299509C Serum-free medium useful for cultivating human monoclonal antibody-producing human/human hybridoma
04/28/1992CA1299508C Human pancreatic elastase i
04/27/1992WO1992007946A1 Protectants for microbial fermentation
04/27/1992WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof
04/27/1992CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof
04/27/1992CA2054232A1 Oasomycins, a process for the preparation thereof and the use thereof
04/27/1992CA2052827A1 Increased production of thermus aquaticus dna polymerase in e.coli
04/26/1992WO1992007582A1 Corynebacteria and related organisms as vaccine vectors
04/26/1992CA2094718A1 Corynebacteria and related organisms as vaccine vectors
04/25/1992CA2054069A1 Expression system
04/24/1992WO1992006994A1 Identification of a suppressor of atherogenic apolipoprotein
04/24/1992CA2093672A1 Identification of a suppressor of atherogenic apolipoprotein
04/24/1992CA2044781A1 Spheroplast fusions of phaffia rhodozyma cells
04/23/1992DE4030264A1 Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren Process for the preparation of purified glycolipids by membrane separation process
04/22/1992EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria
04/22/1992EP0481791A2 Culture medium for CHO-cells and adapted CHO-cells
04/22/1992EP0481790A2 Antibody production
04/22/1992EP0481785A2 Xanthomonas campestris mutant that produces xanthan gum upon cultivation on lactose or unhydrolyzed whey
04/22/1992EP0481712A2 Process for production of optically active methylsuccinic acid
04/22/1992EP0481711A2 Process for production of optically active 3-methyladipic acid
04/22/1992EP0481673A2 Genes encoding the human FK-506 binding protein and a S. cerevisiae homolog, FKB1, and their expression
04/22/1992EP0481672A1 5Beta- and 13beta ivermectin monoglucopyranosides
04/22/1992EP0481072A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
04/22/1992EP0481070A1 Multimeric gelsolin fusion constructs
04/22/1992EP0481008A1 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector
04/22/1992EP0481000A1 Receptors for fibroblast growth factors